T-cell lymphoma is a type of blood cancer that affects the T-cells, which are a part of your immune system. This study aims to collect information about people with T-cell lymphoma to help doctors find better treatments in the future. To be part of this study, you need to give written permission and have a tumor sample available. You must also have one of the specific types of T-cell lymphoma listed by doctors. This includes many types like mycosis fungoides and anaplastic large cell lymphoma. However, if you're not receiving treatment for certain types, you cannot join. The study won't interfere with other treatments or trials you might be a part of.
Remember, participating in this study could help improve future treatments for T-cell lymphoma patients.
NCT05978141
Memorial Sloan Kettering Cancer Center
27 June 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.